• English
  • Polish
biuro@scopefluidics.com +48 22 376 21 14
scope-logo
  • About
  • Team
  • Our offer
  • Knowledge base
  • News
  • Investor relations
  • Career
  • Contact
enpl
  • English
  • Polish
biuro@scopefluidics.com +48 22 376 21 14
scope-logo
  • About
  • Team
  • Our offer
  • Knowledge base
  • News
  • Investor relations
  • Career
  • Contact
biuro@scopefluidics.com +48 22 376 21 14

NEWS

18.01.2023

Scope Fluidics S.A. moves to the Warsaw Stock Exchange (WSE) main market

READ MORE
Piotr Garstecki
16.12.2022

Piotr Garstecki reaches TOP 3 in Forbes Poland magazine’s Polish Business Leader 2022 ranking

READ MORE
13.12.2022

Scope Fluidics among participants at J.P. Morgan Health Care Conference 2023

READ MORE
02.12.2022

Scope Fluidics named Stock Exchange Company of the Year by Forbes Polska magazine

READ MORE
14.11.2022

Scope Fluidics reports excellent financial position

READ MORE
14.09.2022

Forbes: Piotr Garstecki. Polish Professor Breaks the Bank

READ MORE
04.08.2022

Bio-Rad Acquires Curiosity Diagnostics

READ MORE
30.06.2022

Scope Fluidics starts distribution of PCR|ONE system

READ MORE
PCR|ONE
28.04.2022

Scope Fluidics S.A. completes certification clinical trials for its SARS-CoV-2 panel and commences certification clinical trials for its MRSA/MSSA panel

READ MORE
1 2 3 4 … 10

Contact Us


Tel. +48 22 376 21 14
E-mail: biuro@scopefluidics.com
Adress

Ogrodowa 58 Street
9th floor
00-876 Warsaw
KRS: 0000668408

NIP: 527-264-59-89

REGON: 142-754-170

LEI: 259400EUNFX4E2BEHU15

The company is registered in the District Court for the capital city of Warsaw in Warsaw, 14th Commercial Division of the National Court Register.

Share capital: 272 593,00 zł,

Bank Account Number: 03 2490 0005 0000 4520 3046 2136
Terms of use

Cookies Policy
Scope Fluidics 2022 ® All rights reserved